SKB410

· Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SKB410, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: SKB410 for Injection in Solid Tumors [Phase 1]